136 related articles for article (PubMed ID: 23646655)
1. Enhanced distribution and anti-tumor activity of ergosta-4,6,8(14),22-tetraen-3-one by polyethylene glycol liposomalization.
Sun Y; Ji Z; Zhao Y; Liang X; Hu X; Fan J
J Nanosci Nanotechnol; 2013 Feb; 13(2):1435-9. PubMed ID: 23646655
[TBL] [Abstract][Full Text] [Related]
2. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
[TBL] [Abstract][Full Text] [Related]
3. Enhanced pharmacokinetics and anti-tumor efficacy of PEGylated liposomal rhaponticin and plasma protein binding ability of rhaponticin.
Sun Y; Zhao Y
J Nanosci Nanotechnol; 2012 Oct; 12(10):7677-84. PubMed ID: 23421127
[TBL] [Abstract][Full Text] [Related]
4. Folate-functionalized nanoparticles for controlled ergosta-4,6,8(14),22-tetraen-3-one delivery.
Liang X; Sun Y; Liu L; Ma X; Hu X; Fan J; Zhao Y
Int J Pharm; 2013 Jan; 441(1-2):1-8. PubMed ID: 23262423
[TBL] [Abstract][Full Text] [Related]
5. [Research progress on pharmacology, pharmacokinetics and determination of ergosta-4,6,8 (14),22-tetraen-3-one].
Chen H; Chen DQ; Li QF; Li PF; Chen H; Zhao YY
Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):3905-9. PubMed ID: 25751937
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
[TBL] [Abstract][Full Text] [Related]
7. Ergosta-4,6,8(14),22-tetraen-3-one induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells.
Zhao YY; Shen X; Chao X; Ho CC; Cheng XL; Zhang Y; Lin RC; Du KJ; Luo WJ; Chen JY; Sun WJ
Biochim Biophys Acta; 2011 Apr; 1810(4):384-90. PubMed ID: 21241775
[TBL] [Abstract][Full Text] [Related]
8. PEGylated hyaluronic acid-coated liposome for enhanced in vivo efficacy of sorafenib via active tumor cell targeting and prolonged systemic exposure.
Mo L; Song JG; Lee H; Zhao M; Kim HY; Lee YJ; Ko HW; Han HK
Nanomedicine; 2018 Feb; 14(2):557-567. PubMed ID: 29248675
[TBL] [Abstract][Full Text] [Related]
9. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer.
Iinuma H; Maruyama K; Okinaga K; Sasaki K; Sekine T; Ishida O; Ogiwara N; Johkura K; Yonemura Y
Int J Cancer; 2002 May; 99(1):130-7. PubMed ID: 11948504
[TBL] [Abstract][Full Text] [Related]
10. Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes.
Sadzuka Y; Kishi K; Hirota S; Sonobe T
J Liposome Res; 2003 May; 13(2):157-72. PubMed ID: 12855110
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive study of the drug delivery properties of poly(l-lactide)-poly(ethylene glycol) nanoparticles in rats and tumor-bearing mice.
Shalgunov V; Zaytseva-Zotova D; Zintchenko A; Levada T; Shilov Y; Andreyev D; Dzhumashev D; Metelkin E; Urusova A; Demin O; McDonnell K; Troiano G; Zale S; Safarovа E
J Control Release; 2017 Sep; 261():31-42. PubMed ID: 28611009
[TBL] [Abstract][Full Text] [Related]
12. A sensitive spectrofluorometric method for determination of ergosta-4,6,8(14),22-tetraen-3-one in rat plasma, feces, and urine for application to pharmacokinetic studies using cerium(III) as a probe.
Sun Y; Liang X; Zhao Y; Fan J
Appl Spectrosc; 2013 Jan; 67(1):106-11. PubMed ID: 23317677
[TBL] [Abstract][Full Text] [Related]
13. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model.
Eldin NE; Abu Lila AS; Kawazoe K; Elnahas HM; Mahdy MA; Ishida T
Eur J Pharm Sci; 2016 Jan; 81():60-6. PubMed ID: 26415830
[TBL] [Abstract][Full Text] [Related]
14. Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy.
Kajiwara E; Kawano K; Hattori Y; Fukushima M; Hayashi K; Maitani Y
J Control Release; 2007 Jul; 120(1-2):104-10. PubMed ID: 17509714
[TBL] [Abstract][Full Text] [Related]
15. Tumor-type-dependent vascular permeability constitutes a potential impediment to the therapeutic efficacy of liposomal oxaliplatin.
Abu Lila AS; Matsumoto H; Doi Y; Nakamura H; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):524-31. PubMed ID: 22554766
[TBL] [Abstract][Full Text] [Related]
16. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery.
He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X
Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome.
Wang X; Li Y; Wang D; Wang X; Yuan W; Zhao W; Xia G
Pharm Dev Technol; 2021 Jan; 26(1):110-118. PubMed ID: 33104406
[TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model.
Abu Lila AS; Kizuki S; Doi Y; Suzuki T; Ishida T; Kiwada H
J Control Release; 2009 Jul; 137(1):8-14. PubMed ID: 19285528
[TBL] [Abstract][Full Text] [Related]
19. Liposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activity.
Li C; Wang C; Yang H; Zhao X; Wei N; Cui J
J Pharm Pharmacol; 2012 Mar; 64(3):372-82. PubMed ID: 22309269
[TBL] [Abstract][Full Text] [Related]
20. Ergosta-4,6,8(14),22-tetraen-3-one isolated from Polyporus umbellatus prevents early renal injury in aristolochic acid-induced nephropathy rats.
Zhao YY; Zhang L; Mao JR; Cheng XH; Lin RC; Zhang Y; Sun WJ
J Pharm Pharmacol; 2011 Dec; 63(12):1581-6. PubMed ID: 22060289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
